This clinical trial focuses on studying testosterone supplementation in male patients receiving supportive care who have androgen deficiency. The study will use Sustanon 250, which is an injectable solution containing four different forms of testosterone: testosterone decanoate, testosterone isocaproate, testosterone phenylpropionate, and testosterone propionate. The purpose is to evaluate how testosterone supplementation affects quality of life in patients who are receiving supportive care.
The study will examine how testosterone treatment influences daily activities and various symptoms that patients may experience. These activities include personal care tasks, while the symptoms being monitored include physical conditions such as fatigue, pain, and breathing difficulties, as well as emotional well-being. The medication will be given through intravenous administration, and patients will be monitored over time to assess any improvements in their overall condition and independence in daily activities.
During the study, healthcare providers will regularly assess patients’ ability to perform everyday tasks and their general well-being. The assessment will include monitoring how well patients can take care of themselves and how they feel in terms of various physical and emotional symptoms. The study will also consider feedback from people close to the patients about changes in their quality of life.
Belgium 
